相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial
Sulggi A. Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
Line K. Vibholm et al.
JOURNAL OF VIROLOGY (2019)
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+individuals
Line K. Vibholm et al.
AIDS (2019)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2019)
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
Mariane H. Schleimann et al.
EBIOMEDICINE (2019)
In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV plus individuals
Carolina Garrido et al.
AIDS (2019)
Humanized mice: models for evaluating NeuroHIV and cure strategies
Jenna B. Honeycutt et al.
JOURNAL OF NEUROVIROLOGY (2018)
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
A. R. krarup et al.
MUCOSAL IMMUNOLOGY (2018)
Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals
Anni Winckelmann et al.
AIDS (2018)
Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin
Sofie Jorgensen et al.
AIDS (2018)
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure
Rebecca Rose et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
The Spleen Is an HIV-1 Sanctuary During Combined Antiretroviral Therapy
David J. Nolan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
T cells establish and maintain CNS viral infection in HIV-infected humanized mice
Jenna B. Honeycutt et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits &ITEx Vivo&IT Lipopolysaccharide-Induced Inflammatory Responses
Christel Rothe Brinkmann et al.
MSPHERE (2018)
Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption
Ching-Lan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs
G. Tapia et al.
JOURNAL OF INFECTION (2017)
In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies
Christopher C. Nixon et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption
Wen Shi Lee et al.
JOURNAL OF VIROLOGY (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Jenna B. Honeycutt et al.
NATURE MEDICINE (2017)
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal
Guoxin Wu et al.
JCI INSIGHT (2017)
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line Vibholm et al.
CLINICAL INFECTIOUS DISEASES (2017)
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy
Talia M. Mota et al.
AIDS (2017)
Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations
Anni Winckelmann et al.
AIDS (2017)
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Carolina Gutierrez et al.
AIDS (2016)
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells
Lachlan R. Gray et al.
JOURNAL OF NEUROVIROLOGY (2016)
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research
Paul W. Denton et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer
Rebecca Rose et al.
JOURNAL OF VIROLOGY (2016)
HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads
Susanna L. Lamers et al.
JOURNAL OF VIROLOGY (2016)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo et al.
NATURE (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks et al.
NATURE MEDICINE (2016)
PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
Riddhima Banga et al.
NATURE MEDICINE (2016)
Latency reversal and viral clearance to cure HIV-1
David M. Margolis et al.
SCIENCE (2016)
Broad activation of latent HIV-1 in vivo
Kirston Barton et al.
NATURE COMMUNICATIONS (2016)
Tissue reservoirs of HIV
Joseph K. Wong et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Animal Models for HIV Cure Research
Benjamin B. Policicchio et al.
FRONTIERS IN IMMUNOLOGY (2016)
Combined eff ect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth et al.
LANCET HIV (2016)
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
Anne Sofie Hogh Kolbaek Kjaer et al.
AIDS (2015)
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
Beatriz Mothe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat
Rikke Olesen et al.
JOURNAL OF VIROLOGY (2015)
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
Ane Bjerg Christensen et al.
MEDIATORS OF INFLAMMATION (2015)
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
Yoshinori Fukazawa et al.
NATURE MEDICINE (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
Thomas A. Rasmussen et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques
Gregory Q. Del Prete et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
Nancy M. Archin et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Analysis of Multiply Spliced Transcripts in Lymphoid Tissue Reservoirs of Rhesus Macaques Infected with RT-SHIV during HAART
Jesse D. Deere et al.
PLOS ONE (2014)
Recombination-mediated escape from primary CD8+T cells in acute HIV-1 infection
Adam John Ritchie et al.
RETROVIROLOGY (2014)
The lungs as anatomical reservoirs of HIV infection
Cecilia T. Costiniuk et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Is the central nervous system a reservoir of HIV-1?
Lachlan R. Gray et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
Persistence of Viral Reservoirs in Multiple Tissues after Antiretroviral Therapy Suppression in a Macaque RT-SHIV Model
Christopher Kline et al.
PLOS ONE (2013)
HIV Compartmentalization: A Review on a Clinically Important Phenomenon
Jason T. Blackard
CURRENT HIV RESEARCH (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy
Mariko Horiike et al.
VIROLOGY (2012)
Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection
Teresa H. Evering et al.
PLOS PATHOGENS (2012)
Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy
Duncan Chege et al.
AIDS (2011)
Replication-Competent Simian Immunodeficiency Virus (SIV) Gag Escape Mutations Archived in Latent Reservoirs during Antiretroviral Treatment of SIV-Infected Macaques
Suzanne E. Queen et al.
JOURNAL OF VIROLOGY (2011)
The Gut Mucosal Viral Reservoir in HIV-Infected Patients Is Not the Major Source of Rebound Plasma Viremia following Interruption of Highly Active Antiretroviral Therapy
Paula Lerner et al.
JOURNAL OF VIROLOGY (2011)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy
Steven A. Yukl et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Simian Immunodeficiency Virus-Infected Macaques Treated with Highly Active Antiretroviral Therapy Have Reduced Central Nervous System Viral Replication and Inflammation but Persistence of Viral DNA
M. Christine Zink et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS
Thomas W. North et al.
JOURNAL OF VIROLOGY (2010)
Cycling of gut mucosal CD4+T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels
E. J. Ciccone et al.
MUCOSAL IMMUNOLOGY (2010)
Extensive Astrocyte Infection Is Prominent in Human Immunodeficiency Virus-Associated Dementia
Melissa J. Churchill et al.
ANNALS OF NEUROLOGY (2009)
A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy
Jason B. Dinoso et al.
JOURNAL OF VIROLOGY (2009)
Immune-driven recombination and loss of control after HIV superinfection
Hendrik Streeck et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Compartmentalization of the gut viral reservoir in HIV-1 infected patients
Guido van Marle et al.
RETROVIROLOGY (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model
SA Barber et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
QS Li et al.
NATURE (2005)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
JJ Mattapallil et al.
NATURE (2005)
The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: A model for human immunodeficiency virus patients on highly active antiretroviral therapy
JE Clements et al.
JOURNAL OF NEUROVIROLOGY (2005)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
S Mehandru et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates
SL Berg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy
AD Shen et al.
JOURNAL OF VIROLOGY (2003)
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects
PA Anton et al.
AIDS (2003)
Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
M Guadalupe et al.
JOURNAL OF VIROLOGY (2003)
分享论文
